FDA 510(k)

WAKO AUTOKIT LP(A) AND LP(A) CALIBRATOR/COBAS FARA

K-Number: K001929 · 2000-07-24

Decision Date2000-07-24

Product CodeDFC

Advisory CommitteeIM

DecisionSubstantially Equivalent

Device Summary

WAKO AUTOKIT LP(A) AND LP(A) CALIBRATOR/COBAS FARA is the device name listed in this FDA 510(k) record. The listed applicant is Wako Chemicals USA, Inc.. It received FDA 510(k) clearance on 2000-07-24 under 510(k) number K001929. The device is classified under product code DFC. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the WAKO AUTOKIT LP(A) AND LP(A) CALIBRATOR/COBAS FARA?

WAKO AUTOKIT LP(A) AND LP(A) CALIBRATOR/COBAS FARA is a medical device that received FDA 510(k) clearance on 2000-07-24. The listed applicant is Wako Chemicals USA, Inc.. The 510(k) number is K001929.

When did WAKO AUTOKIT LP(A) AND LP(A) CALIBRATOR/COBAS FARA receive FDA 510(k) clearance?

WAKO AUTOKIT LP(A) AND LP(A) CALIBRATOR/COBAS FARA received FDA 510(k) clearance on 2000-07-24, under 510(k) number K001929.

Who is the listed applicant for WAKO AUTOKIT LP(A) AND LP(A) CALIBRATOR/COBAS FARA?

The FDA 510(k) record lists Wako Chemicals USA, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for WAKO AUTOKIT LP(A) AND LP(A) CALIBRATOR/COBAS FARA?

The FDA product code for WAKO AUTOKIT LP(A) AND LP(A) CALIBRATOR/COBAS FARA is DFC.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Wako Chemicals USA, Inc. as applicant

K100464UTASWAKO I30 (INCLUDES ACCESSORIES), UTASWAKO AFP-L3, CALIBRATOR SET, CONTROL L, CONTROL H, SAMPLE DILUTION K080125APOLOWAKO T-CHO, HDL-C, TG AND ANALYZER, MODELS 993-23501, 999-23601, 995-23701 AND 993-25201 K080123APOLOWAKO HBA1C, GLUCOSE AND ANALYZER, MODELS 993-24601, 991-24401 AND 993-25201 K061775WAKO L-TYPE CREATININE-M TEST, AND WAKO CREATININE CALIBRATOR K062368WAKO LBA DCP TEST SYSTEM, MODEL 993-05301; DCP CONTROL SET, MODEL 995-0551; DCP CALIBRATOR SET, LIBASYS, MODEL 999-05401 K053132WAKO DIRECT BILIRUBIN V, MODELS 996-23591, 412-22901, 992-23691, 998-23791

View all 123 devices →

Related Devices (Code: DFC)

K253069Lipoprotein (a) Molarity AssayDiazyme Laboratories, Inc.K241220Tina-quant Lipoprotein(a) Gen.2 MolarityRoche Diagnostics Operations K211058Lp(a) UltraSENTINEL CH. SpA K180074Diazyme Lipoprotein (a) AssayDiazyme Laboratories, Inc.K123046ADVIA CHEMISTRY LIPOPROTEIN(A) REAGENT ADVIA CHEMISTRY LIPOPROTEIN(A) CALIBRATORSiemens Healthcare Diagnostics, Inc.K122722COBAS C TINA-QUANT LIPOPROTEIN (A) GEN 2 ASSAY MODEL 05852625190; PRECISET LP (A) GEN 2 CALIFRATOR SET MODEL 05852641160Roche Diagnostics

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.